Navigation Links
Coronary heart disease bids Adieu

According to a report in The Journal of the American Medical Association. Coronary heart disease is reduced by lowering plasma homocystine levels with a diet supplement of folic acid alone or in combination with cyanocobalamin.

Dr.Tice from the University of California at San Francisco and colleagues used the Coronary Heart Disease Policy Model to assess the cost effectiveness of lowering levels of homocystine through grains fortified with folic acid and with cyanocobalamin and folic acid among participants in the third National Health and Nutrition Examination Survey.//

Their model predicted that grains fortified with folic acid could reduce myocardial infarction by 13% in men and 8% in women, with comparable reductions in death from CHD. "Using our most conservative assumptions, the estimated reductions in annual CHD mortality rates were 1% to 3%," the researchers report.

In addition to consuming fortified grains, if all patients with CHD received 1 mg of folic acid plus 0.5 mg of cyanocobalamin per day, the model projected that there would be approximately 310,000 fewer deaths and lower CHD-related costs over 10 years, compared with consuming folic-acid-fortified grains alone.

Over the same 10-year period, the model also predicted that for men 45 years of age or older without CHD, folic acid and cyanocobalamin supplementation given in addition to fortified grains would save more than 300,000 quality adjusted life-years. In addition, for women 55 years of age and older without CHD, the same strategy would result in 140,000 quality adjusted life-years saved, Dr.Tice's group calculated.


'"/>




Page: 1

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. Coronary stent leads to complications
3. Older Men Surviving Coronary Bypasses
4. The Link Between Oxidized Phospholipids And Coronary Artery Disease
5. Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease
6. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
7. Effectiveness Of Drug-Releasing Coronary Stents
8. Children Are At The Risk Of Inheriting Coronary Disease
9. Statin Therapy in Patients with Acute Coronary Syndrome Improves Survival
10. Meditation may Improve Cardiac Risk Factors in Patients with Coronary Heart Disease
11. Microcirculation in Eye May Indicate Coronary Heart Death Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... CA (PRWEB) , ... February 13, 2016 , ... With ... particle overlays to footage all within Final Cut Pro X. Each user can select ... over 3D rotation, angle of view, blur, focus offset, hue, saturation, value, contrast, glow, ...
(Date:2/13/2016)... Salt Lake City, Utah (PRWEB) , ... February 13, 2016 , ... When an ... kids, Host Parents aren’t always sure what they are in for and they are often ... Pairs are more than they were hoping for. This year’s Au Pair of the Year ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House presents Valentine’s Day tips ... biography of Rama - Dr. Frederick Lenz. , According to Publisher Roger ... Buddhist teacher for teaching and helping others. Valentine’s Day celebrates love in all ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... ... February 12, 2016 , ... Coco Libre, the maker of coconut water ... LA GRAMMY’s Style Lounge Event. Coco Libre will offer musicians and celebrities the company’s ... big event. The invitation-only gifting suite, held this year at the W Hollywood Hotel, ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... 11, 2016 The primary goal of this ... patterns on the usage of liquid biopsy. Key information ... - Timeframe of liquid biopsy adoption amidst future ... Evs—by organization type - Sample inflow to conduct liquid ... stool, serum, and so on. - Correlation analysis of ...
(Date:2/11/2016)... , Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... and improving the lives of pets, today announced the ... the New Animal Drug Application (NADA) for Zimeta™ (dipyrone ... study (KB0120) of Zimeta for the control of pyrexia ... --> --> The ...
Breaking Medicine Technology: